drugset / Trial / NCT00704249

VENICE Study Nevirapine Full Dose/Dose Escalation

NCT00704249

Phase 4 Completed 80 enrolled Clinical Trial Agency of HIV Study Group
RandomizedParallel-groupOpen-label

Summary

This study aims to compare the trough plasma concentrations of nevirapine after 7 days of treatment at the full dose from baseline with dose escalation in patients taking efavirenz who switch to nevirapine due to neuropsychiatric adverse reactions.

Timeline

Start
2006-07
Primary completion
2008-07
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nevirapine Small molecule 200 mg